Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2025-12-27 @ 6:24 AM
Study NCT ID:
NCT02987166
Status:
COMPLETED
Last Update Posted:
2020-12-16
First Post:
2016-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HDCRT Plus Pembrolizumab in Advanced Malignancies
Sponsor:
James Larner, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-21
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-10
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-30
First Submit QC Date:
None
Study First Post Date:
2016-12-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-11
Last Update Post Date:
2020-12-16
Last Update Post Date Type:
ACTUAL